NCT00480740View on ClinicalTrials.gov

The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Cardiac TransplantPatent Ductus ArteriousAtrial Septal DefectBidirectional Cavopulmonary Anastomosis
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine load of 1 microgram/kilogram over 10 minutes, followed by a 1 microgram/kilogram/hour infusion during the time of catheterization

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER